Search Results

There are 5994 results for: content related to: Plasma trough levels of adalimumab and infliximab in terms of clinical efficacy during the treatment of psoriasis

  1. You have free access to this content
    Infliximab dose escalation vs. initiation of adalimumab for loss of response in Crohn’s disease: a cost-effectiveness analysis

    Alimentary Pharmacology & Therapeutics

    Volume 26, Issue 11-12, December 2007, Pages: 1509–1520, G. G. KAPLAN, C. HUR, J. KORZENIK and B. E. SANDS

    Version of Record online : 11 OCT 2007, DOI: 10.1111/j.1365-2036.2007.03548.x

  2. Etanercept for patients with psoriasis who did not respond or who lost their response to adalimumab or infliximab

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue 8, August 2015, Pages: 1576–1581, R. Bissonnette, C. Maari, K. Barber, C.W. Lynde and R. Vender

    Version of Record online : 20 JAN 2015, DOI: 10.1111/jdv.12943

  3. You have free access to this content
    TNF-alpha inhibitors for ankylosing spondylitis

    Intervention Review

    The Cochrane Library

    Lara J Maxwell, Jane Zochling, Annelies Boonen, Jasvinder A Singh, Mirella MS Veras, Elizabeth Tanjong Ghogomu, Maria Benkhalti Jandu, Peter Tugwell and George A Wells

    Published Online : 18 APR 2015, DOI: 10.1002/14651858.CD005468.pub2

  4. You have free access to this content
    Treatment effect of adalimumab and infliximab in Japanese psoriasis patients: Results in a single community-based hospital

    The Journal of Dermatology

    Volume 39, Issue 3, March 2012, Pages: 265–268, Shinji NODA, Kyoko MIZUNO and Makoto ADACHI

    Version of Record online : 29 NOV 2011, DOI: 10.1111/j.1346-8138.2011.01312.x

  5. Biologics for rheumatoid arthritis: an overview of Cochrane reviews

    Overview of Reviews

    The Cochrane Library

    Jasvinder A Singh, Robin Christensen, George A Wells, Maria E Suarez-Almazor, Rachelle Buchbinder, Maria Angeles Lopez-Olivo, Elizabeth Tanjong Ghogomu and Peter Tugwell

    Published Online : 7 OCT 2009, DOI: 10.1002/14651858.CD007848.pub2

  6. You have free access to this content
    Prior response to infliximab and early serum drug concentrations predict effects of adalimumab in ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 11-12, December 2014, Pages: 1324–1332, F. Baert, N. Vande Casteele, S. Tops, M. Noman, G. Van Assche, P. Rutgeerts, A. Gils, S. Vermeire and M. Ferrante

    Version of Record online : 2 OCT 2014, DOI: 10.1111/apt.12968

  7. Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease

    Intervention Review

    The Cochrane Library

    Brian W Behm and Stephen J Bickston

    Published Online : 23 JAN 2008, DOI: 10.1002/14651858.CD006893

  8. A pilot study of adalimumab in infliximab-allergic patients

    Inflammatory Bowel Diseases

    Volume 10, Issue 4, July 2004, Pages: 333–338, Adrienne Youdim, Eric A. Vasiliauskas, Stephan R. Targan, Konstantinos A. Papadakis, Andrew Ippoliti, Marla C. Dubinsky, Juan Lechago, Jane Paavola, Jaime Loane, Susie K. Lee, Joanne Gaiennie, Katie Smith, Jason Do and Maria T. Abreu

    Version of Record online : 14 DEC 2006, DOI: 10.1097/00054725-200407000-00002

  9. You have free access to this content
    Interventions for hidradenitis suppurativa

    Intervention Review

    The Cochrane Library

    John R Ingram, Pick-Ngor Woo, Ser Ling Chua, Anthony D Ormerod, Nemesha Desai, Anneke C Kai, Kerry Hood, Tara Burton, Francisco Kerdel, Sarah E Garner and Vincent Piguet

    Published Online : 7 OCT 2015, DOI: 10.1002/14651858.CD010081.pub2

  10. Caspase activation and apoptosis induction by adalimumab: Demonstration in vitro and in vivo in a chimeric mouse model

    Inflammatory Bowel Diseases

    Volume 12, Issue 1, January 2006, Pages: 22–28, Chong Shen, Gert Van Assche, Paul Rutgeerts and Jan L Ceuppens

    Version of Record online : 14 DEC 2006, DOI: 10.1097/01.MIB.0000194185.69800.07

  11. Influence of neutralizing antibodies to adalimumab and infliximab on the treatment of psoriasis

    British Journal of Dermatology

    Volume 170, Issue 4, April 2014, Pages: 922–929, T. Bito, R. Nishikawa, M. Hatakeyama, A. Kikusawa, H. Kanki, H. Nagai, Y. Sarayama, T. Ikeda, H. Yoshizaki, H. Seto, A. Adachi, T. Horikawa, M. Oka and C. Nishigori

    Version of Record online : 15 APR 2014, DOI: 10.1111/bjd.12791

  12. You have free access to this content
    Down-titration and discontinuation strategies of tumor necrosis factor–blocking agents for rheumatoid arthritis in patients with low disease activity

    Intervention Review

    The Cochrane Library

    Noortje van Herwaarden, Alfons A den Broeder, Wilco Jacobs, Aatke van der Maas, Johannes WJ Bijlsma, Ronald F van Vollenhoven and Bart(holomeus) JF van den Bemt

    Published Online : 29 SEP 2014, DOI: 10.1002/14651858.CD010455.pub2

  13. Short-term response to adalimumab in childhood inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 14, Issue 12, December 2008, Pages: 1683–1687, Joshua D. Noe and Marian Pfefferkorn

    Version of Record online : 10 JUL 2008, DOI: 10.1002/ibd.20534

  14. Safety profiles of adalimumab, etanercept and infliximab: a pharmacovigilance study using a measure of disproportionality in a database of spontaneously reported adverse events

    Journal of Clinical Pharmacy and Therapeutics

    Volume 39, Issue 3, June 2014, Pages: 307–313, D. Mendes, C. Alves and F. Batel-Marques

    Version of Record online : 17 MAR 2014, DOI: 10.1111/jcpt.12148

  15. You have free access to this content
    Systematic review with network meta-analysis: the efficacy of anti-tumour necrosis factor-alpha agents for the treatment of ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 39, Issue 7, April 2014, Pages: 660–671, R. W. Stidham, T. C. H. Lee, P. D. R. Higgins, A. R. Deshpande, D. A. Sussman, A. G. Singal, B. J. Elmunzer, S. D. Saini, S. Vijan and A. K. Waljee

    Version of Record online : 9 FEB 2014, DOI: 10.1111/apt.12644

    Corrected by:

    Corrigendum: Corrigendum

    Vol. 42, Issue 1, 130, Version of Record online: 4 JUN 2015

    Corrected by:

    Corrigendum: Corrigendum

    Vol. 39, Issue 11, 1345–1347, Version of Record online: 6 MAY 2014

  16. You have free access to this content
    The decline of anti-drug antibody titres after discontinuation of anti-TNFs: implications for predicting re-induction outcome in IBD

    Alimentary Pharmacology & Therapeutics

    Volume 35, Issue 6, March 2012, Pages: 714–722, S. Ben-Horin, Y. Mazor, H. Yanai, Y. Ron, U. Kopylov, M. Yavzori, O. Picard, E. Fudim, Y. Maor, A. Lahat, D. Coscas, R. Eliakim, I. Dotan and Y. Chowers

    Version of Record online : 30 JAN 2012, DOI: 10.1111/j.1365-2036.2012.04997.x

  17. You have free access to this content
    2016 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 68, Issue S10, October 2016, Pages: 1–4550,

    Version of Record online : 8 NOV 2016, DOI: 10.1002/art.39977

  18. Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis

    Overview of Reviews

    The Cochrane Library

    Jasvinder A Singh, Alomgir Hossain, Amy S Mudano, Elizabeth Tanjong Ghogomu, Maria E Suarez-Almazor, Rachelle Buchbinder, Lara J Maxwell, Peter Tugwell and George A Wells

    Published Online : 8 MAY 2017, DOI: 10.1002/14651858.CD012657

  19. You have free access to this content
    Mechanisms for cytotoxic effects of anti–tumor necrosis factor agents on transmembrane tumor necrosis factor α–expressing cells: Comparison among infliximab, etanercept, and adalimumab

    Arthritis & Rheumatism

    Volume 58, Issue 5, May 2008, Pages: 1248–1257, Hiroki Mitoma, Takahiko Horiuchi, Hiroshi Tsukamoto, Yasuhiro Tamimoto, Yasutaka Kimoto, Ayumi Uchino, Kentaro To, Shin-Ichi Harashima, Nobuaki Hatta and Mine Harada

    Version of Record online : 25 APR 2008, DOI: 10.1002/art.23447

  20. You have free access to this content
    Systematic review: the short-term and long-term efficacy of adalimumab following discontinuation of infliximab

    Alimentary Pharmacology & Therapeutics

    Volume 30, Issue 10, November 2009, Pages: 977–986, C. MA, R. PANACCIONE, S. J. HEITMAN, S. M. DEVLIN, S. GHOSH and G. G. KAPLAN

    Version of Record online : 22 JUL 2009, DOI: 10.1111/j.1365-2036.2009.04101.x